Showing results (41-50 of 527) with videos related to
Sort By:
Pageof 53
Clinical Pharmacology and Therapeutics|December 1, 1994
Discordant effects of enalapril and lisinopril on systemic and renal hemodynamicsA J Apperloo, D de Zeeuw, P E de JongKidney International. Supplement|August 20, 2005
The kidney, a cardiovascular risk marker, and a new target for therapyDick de Zeeuw, Hans L Hillege, Paul E de JongClinical Science (London, England : 1979)|September 1, 1991
Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of actionJ E Heeg, P E de Jong, D de ZeeuwRadiology|June 1, 1987
Deep venous thrombosis of the leg: US findingsP T Appelman, T E De Jong, L E LampmannNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Measurement of glomerular charge selectivity in non-diabetic renal diseaseM H Hemmelder, D de Zeeuw, P E de JongBurns : Journal of the International Society for Burn Injuries|May 17, 2015
Rigorous, robust and systematic: Qualitative research and its contribution to burn care. An integrative reviewRachel Anne Kornhaber, A E E de Jong, L McLeanKidney International|May 1, 1992
Atrial natriuretic factor: its (patho)physiological significance in humansD de Zeeuw, W M Janssen, P E de JongJournal of Biotechnology|August 14, 2001
Analysis of retted and non retted flax fibres by chemical and enzymatic meansC Mooney, T Stolle-Smits, H Schols, et al.The Canadian Journal of Cardiology|August 1, 1995
Losartan in patients with renal insufficiencyD de Zeeuw, R T Gansevoort, P E de JongAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Treatment of anemia of nephrotic syndrome with recombinant erythropoietinR T Gansevoort, N D Vaziri, P E de JongPageof 53